Compare AU
Compare IXJ vs. A200
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the iShares Global Healthcare ETF (IXJ) and the BetaShares Australia 200 ETF (A200). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
IXJ | A200 | |
|---|---|---|
Popularity | Low | Medium |
Pearlers invested | 240 | 4,877 |
Median incremental investment | $1,000.00 | $1,077.46 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,707.00 | $3,626.74 |
Average age group | 26 - 35 | 26 - 35 |
Key Summary
IXJ | A200 | |
|---|---|---|
Strategy | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks | BetaShares Australia 200 ETF (ASX: A200) seeks to track the performance of the Solactive Australia 200 index before account fees, expenses, and taxes. The index tracks the largest 200 companies on the Australian Securities Exchange (ASX). |
Top 3 holdings | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) | COMMONWEALTH BANK OF AUSTRALIA (10.75 %) BHP GROUP LTD (8.22 %) CSL LTD (5.45 %) |
Top 3 industries | Other (99.98 %) Communication Services (0.02 %) | Financials (33.72 %) Materials (18.17 %) Health Care (8.79 %) |
Top 3 countries | United States (99.97 %) | Australia (95.07 %) United States (3.04 %) New Zealand (1.41 %) |
Management fee | 0.46 % | 0.04 % |
Key Summary
IXJ | A200 | |
|---|---|---|
Issuer | iShares | BetaShares |
Tracking index | S&P Global 1200 Healthcare Sector Index - AUD | Solactive Australia 200 Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.46 % | 0.04 % |
Price | $138.04 | $140.68 |
Size | $1.408 billion | $6.134 billion |
10Y return | 136.31 % | N/A |
Annual distribution yield (5Y) | 1.26 % | 5.25 % |
Market | ASX | ASX |
First listed date | 11/03/2009 | 08/05/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
IXJ | A200 | |
|---|---|---|
Popularity | Low | Medium |
Pearlers invested | 240 | 4,877 |
Median incremental investment | $1,000.00 | $1,077.46 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,707.00 | $3,626.74 |
Average age group | 26 - 35 | 26 - 35 |
Pros and Cons
IXJ | A200 | |
|---|---|---|
Pros |
|
|
Cons |
|
|
IXJ | A200 |
|---|---|
Lower exposure to AU market | Higher exposure to AU market |
Higher exposure to US market | Lower exposure to US market |
Higher management fee | Lower management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |